Proficiency Testing Program for Hb E (HBB: c.79G>A) Screening in Thailand Using Lyophilized Hb E Control Materials

被引:0
|
作者
Pornprasert, Sakorn [1 ]
Surajinda, Sirithorn [2 ]
Pongpunyayuen, Panida [2 ]
Punyamung, Manoo [2 ]
Ruengdit, Chedtapak [1 ]
Intasai, Nutjeera [1 ]
机构
[1] Chiang Mai Univ, Fac Associated Med Sci, Dept Med Technol, 110 Intawaroros Rd, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Fac Associated Med Sci, Associated Med Sci Clin Serv Ctr, Chiang Mai, Thailand
关键词
Control materials; dichlorophenol-indophenol; Hb E (HBB c.79G > A); microcolumn chromatography; proficiency testing (PT) program; HEMOGLOBIN-E; THALASSEMIA;
D O I
10.1080/03630269.2020.1734612
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The dichlorophenol-indophenol (DCIP) test and microcolumn chromatography are simple methods commonly used for screening of Hb E (HBB: c.79G>A) in Thailand. However, there is no proficiency testing (PT) program for these screening tests. Thus, the aim of this study was to evaluate an efficiency of lyophilized hemoglobin (Hb) control materials used in the established PT program for Hb E screening at the Associated Medical Sciences-Clinical Service Center (AMS-CSC), Chiang Mai University, Chiang Mai, Thailand. Three cycles of PT were performed from June 2018 to July 2019. In each cycle, five different types of control materials were provided to the participants. Each participant analyzed the control materials in the same manner as in their routine practices for Hb E screening. The results showed that the number of participants increased from 95 in the first cycle to 126 and 134 in the second and third cycles, respectively. The numbers of participants who used the DCIP screening test and reported the result correctly increased from 79 (85.87%) to 106 (89.08%) and 112 (89.60%), respectively. Whereas those who used the microcolumn chromatography method and reported correct results were decreased from 100.0 to 85.71 and 66.67%, respectively. Thus, lyophilized Hb, control materials can be used effectively for the PT program of Hb E screening test. However, the further improvement, especially in skills of Hb E analysis by microcolumn chromatography, is required for some participating laboratories.
引用
收藏
页码:82 / 85
页数:4
相关论文
共 38 条
  • [21] Hb Alesha [β67( E11) Val→Met (GTG> ATG); HBB: c. 202G> A] Found in a Chinese Girl
    Jiang, Hua
    Yan, Jin-Mei
    Zhou, Jian-Ying
    Li, Dong-Zhi
    HEMOGLOBIN, 2016, 40 (06) : 420 - 421
  • [22] Coinheritance of Hb Bristol-Alesha [β67(E11)Val→Met; HBB: c.202G>A] and the α212 Patchwork Allele in a Brazilian Child with Severe Congenital Hemolytic Anemia
    Pedroso, Gisele A.
    Kimura, Elza M.
    Santos, Magnun N. N.
    Albuquerque, Dulcineia M.
    Ferruzzi, Jucilane L. H.
    Jorge, Susan E.
    Costa, Fernando F.
    Saad, Sara T. O.
    Sonati, Maria F.
    HEMOGLOBIN, 2017, 41 (03) : 203 - 208
  • [23] Hb Ullevaal [β78(EF2)Leu→Val; HBB: c.235C>G], a New Hemoglobin Variant Interfering with Hb A1c Measurement Using a Cation Exchange High Performance Liquid Chromatography Method
    Grimholt, Runa M.
    Sudmann, Ashild A.
    Piehler, Armin P.
    Urdal, Petter
    Klingenberg, Olav
    HEMOGLOBIN, 2014, 38 (02) : 130 - 132
  • [24] Hb Kirikiriroa [α57(E6)Gly→Cys; HBA1: c.172G>T]: A Novel Unstable α-Globin Variant with Oxidized Derivatives Interfering with Hb A1c
    Moore, Jordyn A.
    Pullon, Beverley M.
    Wang, Darrell
    Monaghan, Julie
    Moore, Helen
    HEMOGLOBIN, 2022, 46 (02) : 81 - 86
  • [25] Screening and Diagnosis of Hb Quong Sze [HBA2: c.377T>C (or HBA1)] in a Prenatal Control Program for Thalassemia
    Yang, Yu
    Lou, Ji-Wu
    Liu, Yan-Hui
    He, Yi
    Li, Dong-Zhi
    HEMOGLOBIN, 2014, 38 (03) : 158 - 160
  • [26] Clinical and molecular characterization of hemoglobin Maputo [beta 47 (CD6) Asp > Tyr HBB: c.142G > T] and G-Ferrara [beta 57 (E1) Asn > Lys HBB: c.174C > A] in a newborn screening in Brazil
    Silva, M. R.
    Sendin, S. M.
    Araujo, I. C. O.
    Pimentel, F. S.
    Viana, M. B.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2013, 35 (06) : E1 - E4
  • [27] Phenotypic Expression of Known and Novel Hemoglobin A2-Variants, Hemoglobin A2-Mae Phrik [Delta 52(D3) Asp > Gly, HBD:c.158A > G], Associated with Hemoglobin E [Beta 26(B8) Glu > Lys, HBB:c.79G > A] in Thailand
    Phasit, Amphai
    Panyasai, Sitthichai
    Mayoon, Monthon
    Jettawan, Niphawan
    Satthakarn, Surada
    GENES, 2022, 13 (06)
  • [28] A new unstable variant of the fetal hemoglobin HBG2 gene: Hb F-Turritana [Gγ64(E8)Gly→Asp, HBG2:c.194G>A] found in cis to the Hb F-Sardinia gene [Aγ(E19)Ile→Thr, HBG1:c.227T>C]
    Pirastru, Monica
    Mereu, Paolo
    Trova, Sandro
    Manca, Laura
    Masala, Bruno
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (06) : 510 - 513
  • [29] Hb G-Waimanalo [A1] [α64(E13)Asp→Asn; HBA1: c.193 G>A] with Decreased Oxygen Affinity
    Karow, Axel
    Eekels, Julia J. M.
    Zurbriggen, Karin
    Schmid, Marlis
    Schmugge, Markus
    Speer, Oliver
    HEMOGLOBIN, 2015, 39 (06) : 432 - 434
  • [30] Hb G-Waimanalo [A1] or α64(E13)Asp→Asn (α1) (HBA1: c.193G>A) Observed in a Bulgarian Family
    Petkov, Georgi
    Dimishkovska, Marija
    Ivanova, Vanya Tsoneva
    Yordanov, Georgi
    Zdraveski, Alexandar
    Plaseska-Karanfilska, Dijana
    HEMOGLOBIN, 2015, 39 (06) : 430 - 431